GlassScriptPhysician profile
Amy J Wadas
NPI 1801971684
$6,724.88
in general payments reported to CMS, 2019-2025
11 companies · $355 in 2025
The $355 reported for 2025 was more than what 86% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $708 · 2021: $1,396 · 2022: $2,843 · 2023: $511 · 2024: $342 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713 · Gift: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.76 |
| Gift | $495.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $4,525.90 | 2020-2024 | |
| Biohorizons Implant Systems INC. | $597.09 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Ultradent Products INC | $556.10 | 2019-2025 | Opalescence |
| Dentsply Sirona INC | $397.41 | 2019-2024 | Nupro, Purevac Hve |
| Straumann USA LLC | $313.73 | 2019-2025 | |
| Nobel Biocare USA | $135.08 | 2019-2023 | Nobelactive |
| Patterson Companies, INC. | $62.00 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $61.31 | 2023-2024 | Arestin, Ossix Plus |
| Coltene Whaledent INC. | $44.08 | 2020-2021 | |
| 3m Company | $16.70 | 2023 | Scotchbond Universal Plus, 3m Relyx |
| Colgate Oral Pharmaceuticals, INC. | $15.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.